Impaired retention of technetium-99m tetrofosmin in hypertrophic cardiomyopathy

American Journal of Cardiology

Volumn 87, Issue 6, 2001, Pages 743-747

  Morishita, Satofumi ^a   Kondo, Yuki ^a   Nomura, Masahiro ^a   Miyajima, Hitoshi ^a   Nada, Tomomi ^a   Ito, Susumu ^a   Nakaya, Yutaka ^a  

^a UNIVERSITY OF TOKUSHIMA   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

TETROFOSMIN TC 99M;

ADULT; AGED; ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; DIAGNOSTIC IMAGING; DRUG RETENTION; HEART LEFT VENTRICLE WALL; HEART MUSCLE CELL; HEART MUSCLE INJURY; HUMAN; HYPERTROPHIC CARDIOMYOPATHY; IMAGE ANALYSIS; MEMBRANE POTENTIAL; MITOCHONDRION; PRIORITY JOURNAL; SCORING SYSTEM; SINGLE PHOTON EMISSION COMPUTER TOMOGRAPHY;

CARDIOMYOPATHY, DILATED; CARDIOMYOPATHY, HYPERTROPHIC; ECHOCARDIOGRAPHY; FEMALE; HEART; HUMANS; IMAGE PROCESSING, COMPUTER-ASSISTED; MALE; MIDDLE AGED; ORGANOPHOSPHORUS COMPOUNDS; ORGANOTECHNETIUM COMPOUNDS; RADIOPHARMACEUTICALS; STROKE VOLUME; TOMOGRAPHY, EMISSION-COMPUTED, SINGLE-PHOTON; VENTRICULAR FUNCTION, LEFT;

EID: 0035869179     PISSN: 00029149     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0002-9149(00)01494-6     Document Type: Article

References (28)

1. Hypertrophic cardiomyopathy: Interrelations of clinical manifestations, pathophysiology, and therapy
2. Prognosis in hypertrophic cardiomyopathy
3. Hypertrophic cardiomyopathy and transmural myocardial infarction without significant atherosclerosis of the extramural coronary arteries
4. Progression to left ventricular dilatation in patients with hypertrophic obstructive cardiomyopathy
5. Transmural myocardial infarction on hypertrophic cardiomyopathy: A cause of convention from left ventricular asymmetry to symmetry and from normal-sized to dilated left ventricular cavity
6. Occurrence and significance of progressive wall thinning and relative cavity dilatation on hypertrophic cardiomyopathy
7. Progression from hypertrophic obstructive cardiomyopathy to typical dilated cardiomyopathy-like features in the end stage
8. A case showing a rare evolution from hypertrophic cardiomyopathy to "dilated" cardiomyopathy demonstrated by echocardiography
9. Severe functional limitation in patients with hypertrophic cardiomyopathy and only mild localized left ventricular hypertrophy
10. Are technetium-99m-labeled myocardial perfusion agents adequate for detection of myocardial viability?
11. Hypertrophic nonobstructive cardiomyopathy with giant negative T waves (apical hypertrophy): Ventriculographic and echocardiographic features in 30 patients
12. Hypertrophic cardiomyopathy with ventricular septal hypertrophy localized to the apical region of the left ventricle (apical hypertrophic cardiomyopathy)
13. Apical hypertrophic cardiomyopathy: Evaluation by noninvasive and invasive techniques in 23 patients
14. Asymmetric septal hypertrophy: Echocardiographic identification of the pathogenomonic anatomic abnormality of IHSS
15. Idiopathic hypertrophic subaortic stenosis: Clinical analysis of 126 patients with emphasis on the natural history
16. Progression of hypertrophic cardiomyopathy into a hypokinetic left ventricle: Higher incidence in patients with midventricular obstruction
17. Prognosis in hypertrophic cardiomyopathy: Role of age and clinical, electrocardiographic and hemodynamic features
18. Prospects and predictions for the cardiomyopathies
19. Pathogenisis of hypertrophic cardiomyopathy: Hypothesis and speculations
20. Technetium-99m-tetrofosmin, technetium-99m-MIBI and thallium-201 uptake in rat myocardial cells
21. Mechanism of uptake of technetium-tetrofosmin. Uptake into isolated adult rat heart mitochondria
22. Characterization of Na(+)-H+ antiporter activity associated with human cheek epithelial cells
23. Thallium-201 uptake relates to membrane potential and potassium permeability in human glioma cells
24. Effects of acute ischemia and reperfusion on the myocardial kinetics of technetium 99m-labeled tetrofosmin and thallium-201
25. Cardiac stress- rest single-photon emission computed tomography with technetium 99m-labeled tetrofosmin
26. Relation between extent of cardiac muscle cell disorganization and left ventricular wall thickness in hypertrophic cardiomyopathy
27. Regional myocyte hypertrophy and increased interstitial myocardial fibrosis in hypertrophic cardiomyopathy
28. Temporal image fractionation: Rejection of motion artifacts in myocardial SPECT